CME Group Inc. $CME Holdings Decreased by Banque Pictet & Cie SA

Key Points

• Banque Pictet & Cie SA reduced its stake in CME Group Inc. by 5.2%, now holding 61,642 shares valued at $16.99 million.
• Equities analysts have varying perspectives on CME Group, with Oppenheimer raising the price target to $303.00 while UBS lowered it to $285.00.
• CME Group's latest quarterly earnings showed a 10.4% increase in revenue year-over-year, reporting $1.69 billion and an EPS of $2.96, beating analyst estimates.

Banque Pictet & Cie SA trimmed its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 5.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 61,642 shares of the financial services provider's stock after selling 3,401 shares during the period. Banque Pictet & Cie SA's holdings in CME Group were worth $16,990,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently bought and sold shares of CME. Heartland Bank & Trust Co acquired a new stake in shares of CME Group during the first quarter worth approximately $377,000. Catalyst Capital Advisors LLC increased its stake in CME Group by 256.9% in the 1st quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider's stock valued at $971,000 after buying an additional 2,636 shares during the period. OMNI 360 Wealth Inc. purchased a new stake in CME Group in the 1st quarter worth approximately $367,000. Fulcrum Equity Management acquired a new stake in shares of CME Group during the 1st quarter valued at $258,000. Finally, AIA Group Ltd boosted its stake in shares of CME Group by 17.8% during the 1st quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider's stock valued at $4,416,000 after buying an additional 2,510 shares during the period. 87.75% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the stock. Oppenheimer upped their price target on shares of CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research note on Thursday, July 24th. UBS Group lowered their target price on CME Group from $305.00 to $285.00 and set a "neutral" rating on the stock in a research note on Monday, September 8th. Wall Street Zen downgraded CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Citigroup upgraded CME Group from a "neutral" rating to a "buy" rating and lifted their price target for the company from $275.00 to $300.00 in a report on Thursday. Finally, Barclays set a $298.00 price objective on CME Group and gave the stock an "equal weight" rating in a report on Thursday, July 24th. Five analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $268.14.

CME Group Price Performance

Shares of NASDAQ:CME opened at $268.73 on Friday. The stock has a market capitalization of $96.84 billion, a P/E ratio of 26.01, a P/E/G ratio of 4.79 and a beta of 0.43. The business has a 50-day moving average of $270.96 and a two-hundred day moving average of $270.80. CME Group Inc. has a fifty-two week low of $213.94 and a fifty-two week high of $290.79. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the prior year, the firm posted $2.56 EPS. The firm's revenue for the quarter was up 10.4% on a year-over-year basis. On average, equities research analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were given a $1.25 dividend. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. CME Group's dividend payout ratio (DPR) is currently 48.40%.

Insider Transactions at CME Group

In related news, insider Sunil Cutinho sold 11,896 shares of the company's stock in a transaction on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the sale, the insider directly owned 17,440 shares of the company's stock, valued at approximately $4,734,436.80. This represents a 40.55% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Timothy Francis Mccourt sold 379 shares of the firm's stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the completion of the transaction, the insider owned 9,508 shares in the company, valued at $2,470,463.64. The trade was a 3.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 13,043 shares of company stock worth $3,527,956. 0.30% of the stock is owned by insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.